Assilbek Mussoyev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Assilbek Mussoyev has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Aidar Mukhametkaliyev
Faculty Veterinary and Zooengineering, Kazakh National Agrarian Research University, Almaty 050010, Kazakhstan
1 shared publication - Andrey Bogoyavlenskiy
Research and Production Center for Microbiology and Virology, Almaty 050010, Kazakhstan
1 shared publication - Aziza Temirbayeva
Laboratory of Antiviral Protection, Research and Production Center for Microbiology and Virology, Almaty 050010, Kazakhstan
1 shared publication - Krzysztof Śmietanka
Department of Virology and Viral Animal Diseases, National Veterinary Research Institute, 57 Partyzantów Avenue, 24-100 Puławy, Poland
1 shared publication - Kuralay Akanova
Research and Production Center for Microbiology and Virology, Almaty 050010, Kazakhstan
1 shared publication - Madina Alexyuk
Research and Production Center for Microbiology and Virology, Almaty 050010, Kazakhstan
1 shared publication
Latest Publications
- Open Access
Antiviral Activity of Polyene Macrolides Against Newcastle Disease Virus: Computational and Experimental Insights
The search for novel antiviral agents against Newcastle disease virus (NDV) remains a priority in industrial poultry farming due to the virus’s high contagiousness and associated economic losses, prompting evaluation of polyene macrolides as potential therapeutic candidates. We employed a comprehensive approach combining computational modeling (molecular docking and dynamics simulation) and laboratory experiments to investigate the antiviral potential of natamycin, nystatin, and filipin complex against three NDV strains. Molecular docking analysis indicated binding sites for macrolides within the hydrophobic regions of surface glycoproteins HN and F, with binding energies ranging from −6.5 to −10.5 kcal/mol, while 50 ns molecular dynamics simulation confirmed complex stability. Laboratory testing using fluorescence-based neuraminidase assays demonstrated dose-dependent inhibitory activity with IC50 values of 0.0043 ± 0.0015 mg/mL for filipin complex, 0.0117 ± 0.0029 mg/mL for nystatin, and 0.0220 ± 0.0138 mg/mL for natamycin, with similar ranking observed for fusion inhibition (EC50 values of 0.00053 ± 0.00039, 0.00545 ± 0.00560, and 0.01196 ± 0.00965 mg/mL, respectively). While filipin complex exhibited the highest antiviral activity, its significant cytotoxicity limits therapeutic application, whereas natamycin demonstrated a favorable safety profile consistent with its GRAS status. These findings indicate that natamycin exhibits a favorable safety-to-efficacy profile in vitro, warranting further in vivo investigation to clarify its mechanism of action and establish practical application protocols for NDV control in poultry.
Open AccessAntiviral Activity of Polyene Macrolides Against Newcastle Disease Virus: Computational and Experimental Insights
The search for novel antiviral agents against Newcastle disease virus (NDV) remains a priority in industrial poultry farming due to the virus’s high contagiousness and associated economic losses, prompting evaluation of polyene macrolides as potential therapeutic candidates. We employed a comprehensive approach combining computational modeling (molecular docking and dynamics simulation) and laboratory experiments to investigate the antiviral potential of natamycin, nystatin, and filipin complex against three NDV strains. Molecular docking analysis indicated binding sites for macrolides within the hydrophobic regions of surface glycoproteins HN and F, with binding energies ranging from −6.5 to −10.5 kcal/mol, while 50 ns molecular dynamics simulation confirmed complex stability. Laboratory testing using fluorescence-based neuraminidase assays demonstrated dose-dependent inhibitory activity with IC50 values of 0.0043 ± 0.0015 mg/mL for filipin complex, 0.0117 ± 0.0029 mg/mL for nystatin, and 0.0220 ± 0.0138 mg/mL for natamycin, with similar ranking observed for fusion inhibition (EC50 values of 0.00053 ± 0.00039, 0.00545 ± 0.00560, and 0.01196 ± 0.00965 mg/mL, respectively). While filipin complex exhibited the highest antiviral activity, its significant cytotoxicity limits therapeutic application, whereas natamycin demonstrated a favorable safety profile consistent with its GRAS status. These findings indicate that natamycin exhibits a favorable safety-to-efficacy profile in vitro, warranting further in vivo investigation to clarify its mechanism of action and establish practical application protocols for NDV control in poultry.